Citation

Biftu T, Sinha-Roy R, Chen P, Qian X, Feng D, Kuethe JT, Scapin G, Gao YD, Yan Y, Krueger D, Bak A, Eiermann G, He J, Cox J, Hicks J, Lyons K, He H, Salituro G, Tong S, Patel S, Doss G, Petrov A, Wu J, Xu SS, Sewall C, Zhang X, Zhang B, Thornberry NA, Weber AE.: Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes. J Med Chem, Volume 57 (8), 2014

Authors

Bak A, Biftu T, Chen P, Cox J, Doss G, Eiermann G, Feng D, Gao YD, He H, He J, Hicks J, Krueger D, Kuethe JT, Lyons K, Patel S, Petrov A, Qian X, Salituro G, Scapin G, Sewall C, Sinha-Roy R, Thornberry NA, Tong S, Weber AE., Wu J, Xu SS, Yan Y, Zhang B, Zhang X

Journal

J Med Chem

Year

2014

DOI

10.1021/jm401992e

PubMed

24660890

Machine-readable

REST APIRDF